 |
|
|
| |
Use of Glecaprevir/Pibrentasvir (G/P) for the treatment
of HCV infection among fentanyl users: an interim analysis
of the GRAND PLAN study - High Cure Rates
|
| |
| |
EASL 2022 June 22-26 London
Brian Conway1,2, David Truong1, Leo Yamamoto1, Rossitta Yung1, Shawn Sharma1.
1Vancouver Infectious Diseases Centre, Vancouver, Canada; 2Simon Fraser University, Burnaby, Canada
|
| |
|
|
|
|
|
